Drug Resistance in COVID-19 Patients
A special issue of Antibiotics (ISSN 2079-6382). This special issue belongs to the section "Antibiotic Therapy in Infectious Diseases".
Deadline for manuscript submissions: closed (31 October 2021) | Viewed by 427
Special Issue Editor
Special Issue Information
Dear Colleagues,
In recent times, the increase in Antimicrobial Resistance (AMR) has presented a daunting challenge to human and animal health. Different nations have united to fight against AMR as one of their highest priorities. They have agreed to implement several clinical and microbiological surveillance measures such as AMR stewardship programs, the promotion of rational and controlled antibiotics, and improved vaccination approaches, to name a few. Unfortunately, the ongoing COVID-19 pandemic has negatively affected the accessibility and technical capacity for diagnosis, treatment, and patient care of both COVID-19 and non-COVID-19 patients globally. Unwanted use of antibiotics is a critical factor of AMR. Although antibiotics are not an effective way to treat COVID-19, they have frequently been used during this pandemic. The early evidence suggests that even in lower bacterial co-infected COVID-19 patients, antibiotic use remains high. There is a growing concern that the COVID-19 pandemic may intensify AMR.
In this Special Issue of Antibiotics, we invite original and review articles to deepen our insights into the antimicrobial resistance (AMR) complication in COVID-19 patients as well as pathophysiologic mechanisms and treatment approaches for COVID-19 patients.
Dr. Subhash Chand
Guest Editor
Manuscript Submission Information
Manuscripts should be submitted online at www.mdpi.com by registering and logging in to this website. Once you are registered, click here to go to the submission form. Manuscripts can be submitted until the deadline. All submissions that pass pre-check are peer-reviewed. Accepted papers will be published continuously in the journal (as soon as accepted) and will be listed together on the special issue website. Research articles, review articles as well as short communications are invited. For planned papers, a title and short abstract (about 100 words) can be sent to the Editorial Office for announcement on this website.
Submitted manuscripts should not have been published previously, nor be under consideration for publication elsewhere (except conference proceedings papers). All manuscripts are thoroughly refereed through a single-blind peer-review process. A guide for authors and other relevant information for submission of manuscripts is available on the Instructions for Authors page. Antibiotics is an international peer-reviewed open access monthly journal published by MDPI.
Please visit the Instructions for Authors page before submitting a manuscript. The Article Processing Charge (APC) for publication in this open access journal is 2900 CHF (Swiss Francs). Submitted papers should be well formatted and use good English. Authors may use MDPI's English editing service prior to publication or during author revisions.
